Your only malignant mesothelioma news source!
Click on each item to read full story.

 
Conference on Mesothelioma Co-Hosted with National Cancer Institute
read story
On March 2-4, the Mesothelioma Applied Research Foundation and the National Cancer Institute (NCI) will co-host the annual International Symposium on Malignant Mesothelioma at the National Institutes of Health (NIH). (PRWeb January 30, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12483077.htm
 
Mesothelioma Victims Center Urges all US Homeowners to Review the EPA Fact Sheet on Prevention of Exposure to Asbestos ...
read story
WASHINGTON, Jan. 30, 2015 /PRNewswire/ -- The Mesothelioma Victims Center is urging all US homeowners to familiarize themselves with the dangers of exposure to asbestos in any home constructed with the material as there could be a remote possibility of developing a malignant form of cancer called mesothelioma. Any individual diagnosed with mesothelioma, or family member acting on behalf of a ...
 
Cancer Research Foundation Honors Award Recipients
read story
Last week, the Mesothelioma Applied Research Foundation announced the recipients of its awards, to be presented during the Awards Dinner, on March 2, 2015, at the Hyatt Regency Bethesda, in conjunction with the organization’s annual International Symposium on Malignant Mesothelioma. (PRWeb January 29, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12482090.htm
 
Study Tags Enzyme as New Prognostic Factor for Mesothelioma, According to Surviving Mesothelioma
read story
Cancer Researchers say an enzyme linked with some kinds of blood cancer could be used to help determine prognosis in patients with malignant pleural mesothelioma. (PRWeb January 29, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12474039.htm
 
Study Finds New Radiotherapy Technique More Effective and Safer for Some Mesothelioma Patients, According to Surviving ...
read story
New research suggests that an advanced targeted radiotherapy technique called volumetric modulated arc therapy (VMAT) may beat other types of conformal radiotherapy for certain patients with malignant pleural mesothelioma. (PRWeb January 24, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12464645.htm
 
Mesothelioma Compensation Center Offers Legal Advice to Prevent Complications From a Diagnosed Victim Dying Without a ...
read story
WASHINGTON, Jan. 27, 2015 /PRNewswire/ -- The Mesothelioma Compensation Center says, "This week we want to provide meaningful help for those that call us at 866-714-6466 before hiring a law firm to advance a mesothelioma claim with instant access to the nation's best mesothelioma compensation attorneys, because we know for a fact that these are the best mesothelioma lawyers in the nation." The ...
 
Research Foundation Applauds the DoD for Doubling Its Funding Available for Mesothelioma
read story
The Mesothelioma Applied Research Foundation (Meso Foundation) applauds the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program for doubling the funding available to mesothelioma researchers. (PRWeb January 31, 2015) Read the full story at http://www.prweb.com/releases/2015/02/prweb12486173.htm
 
Surviving Mesothelioma Cites New Danish Report to Warn Homeowners of Potential Home Repair Danger
read story
Mesothelioma education site Surviving Mesothelioma says the cases of two Danish men who contracted mesothelioma after doing home repairs illustrate the dangers of asbestos exposure at home. (PRWeb January 26, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12469344.htm
 
Verastem Receives Orphan Medicinal Product Designation from the European Commission for VS-5584 in Mesothelioma
read story
Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that VS-5584 has received orphan medicinal product designation from the European Commission for use in mesothelioma.
 
New Report Finds Some Mesothelioma Cells Can Be Killed by Lymphoma Drug, According to Surviving Mesothelioma
read story
A newly-released study of the lymphoma drug brentuximab vedotin suggests it may be a treatment alternative for certain mesothelioma patients. (PRWeb January 20, 2015) Read the full story at http://www.prweb.com/releases/2015/01/prweb12452809.htm